Australian oncology-focused biotech Kazia Therapeutics (Nasdaq: KZIA) has reported pre-clinical and translational data ...
Germany’s Merz Therapeutics today announced the appointment of Dan Staner as president, region Europe, effective 1. In this ...
Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has started a review of Amgen’s Tavneos (avacopan), ...
The Delhi High Court in India has upheld the grant of a pharmaceutical patent to privately-held Swiss drugmaker Helsinn ...
Dutch biopharma company Pharming Group saw its shares tumble 13.5% to 1.48 euros this morning after it received a regulatory ...
US pharma major Eli Lilly has announced plans to invest more than $3.5 billion in a new manufacturing facility in the Lehigh ...
Shares of US pharma Aquestive Therapeutics rocketed 45.4% to $4.20 this morning, despite receiving a Complete Response Letter ...
Australian radiopharmaceutical company AdvanCell has entered into a collaboration and exclusive licensing deal with Canadian ...
The European Medicines Agency’s human medicines committee (CHMP) issued multiple positive opinions on new medicines and ...
US genomics specialist Illumina (Nasdaq: ILMN) has completed its acquisition of proteomics company SomaLogic, adding large-scale protein analysis to its multiomics portfolio and strengthening its push ...
French pharma Sanofi (Euronext: SAN) says Phase III results for its oral candidate venglustat improved neurological symptoms in people with type 3 Gaucher disease, a rare inherited disorder. Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results